about
You are how you recruit: a cohort and randomized controlled trial of recruitment strategiesInfluence of common non-synonymous Toll-like receptor 4 polymorphisms on bronchopulmonary dysplasia and prematurity in human infants.Profound lack of interleukin (IL)-12/IL-23p40 in neonates born early in gestation is associated with an increased risk of sepsis.Have infant gross motor abilities changed in 20 years? A re-evaluation of the Alberta Infant Motor Scale normative valuesExogenous surfactant therapy: newer developments.Early inflammation in the absence of overt infection in preterm neonates exposed to intensive carePoractant alfa versus bovine lipid extract surfactant for infants 24+0 to 31+6 weeks gestational age: A randomized controlled trial.A systematic review of intentional delivery in women with preterm prelabor rupture of membranes.A Randomized Controlled Trial of Innovative Postpartum Care Model for Mother-Baby Dyads.Chest computed tomography findings in bronchopulmonary dysplasia and correlation with lung function.Expanded use of surfactant therapy in newborns.Male-biased infant sex ratios and patterns of induced abortion.Next-generation sequencing for diagnosis of rare diseases in the neonatal intensive care unit.Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review and meta-analysis.Empiric acyclovir for neonatal herpes simplex virus infection.That chorioamnionitis is a risk factor for bronchopulmonary dysplasia--the case against.Omega-3 long-chain polyunsaturated fatty acids for extremely preterm infants: a systematic review.A meta-epidemiological study to examine the association between bias and treatment effects in neonatal trials.Newborn bilirubin screening for preventing severe hyperbilirubinemia and bilirubin encephalopathy: a rapid review.Comparative efficacy of intratracheal adeno-associated virus administration to newborn rats.Minimizing blood loss and the need for transfusions in very premature infants.Genome-wide association study of bronchopulmonary dysplasia: a potential role for variants near the CRP gene.The short-term outcome of a large cohort of very preterm infants treated with poractant alfa (Curosurf) for respiratory distress syndrome. A postmarketing phase IV study.Evaluation of the safety of palivizumab in the second season of exposure in young children at risk for severe respiratory syncytial virus infection.The assessment of IgG avidity in the evaluation of perinatal herpes simplex virus infection.Incidence of respiratory syncytial virus-related hospitalizations in high-risk children: follow-up of a national cohort of infants treated with Palivizumab as RSV prophylaxis.A single-center experience of implementing delayed cord clamping in babies born at less than 33 weeks' gestational age.[Perception of the linguistic and cultural context minority on the lived experiences of pregnancy].Neonatal and neurodevelopmental outcomes of very low birth weight infants with histologic chorioamnionitis.A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.Value of a single C-reactive protein measurement at 18 h of age.Limiter les pertes de sang et le recours aux transfusions chez les grands prématurés.Functional genetic variation in NFKBIA and susceptibility to childhood asthma, bronchiolitis, and bronchopulmonary dysplasia.
P50
Q29109879-8B052FE7-56F3-45E8-9C6C-99C3D525D39CQ34163497-BD22C4A7-8531-4A53-8FCB-FB792C51F439Q34286789-06107D0C-AE7A-478A-B2A8-DC867C0C7F2CQ34947017-9A2113D7-60E5-49B6-A895-B9D1DFAA82F7Q35682593-9C916A13-3153-4D39-9C4E-E29976AD9A55Q35828256-9329245E-71F8-48F0-ABFA-99A8C39FFC01Q36362972-A5E3E3B5-B097-4222-86FB-A493C70A1BEDQ36475786-46A64212-1023-4524-B7FD-8C732A2890B1Q36576818-A33262CC-98AD-4C10-82AE-B15F208447C1Q36767388-694D6664-9CC0-4467-BD78-9047412D2DD3Q36774474-98AF91B0-3CE5-4B7C-9711-298AFAE664DAQ36993837-ECD440CC-C323-46B1-B69C-B89433AF99A8Q37162309-90931F45-A298-440A-BF9A-CC3B3FC19CE2Q37893339-3BC004ED-5373-4DEB-BA0E-6AA50766D67BQ37944896-DF8DAA8B-3585-4F5B-BBBC-43EB866D1347Q38152083-E4968869-F6DF-495B-A558-2A1C4ACCC4C3Q38218979-98A6B2FE-20F3-45C9-AAAE-63C60DE8427AQ38287843-9D1FADFD-A7EF-4E29-824D-A6AE4BEE8797Q39077917-4D2ABEEA-4776-4C2C-9AE4-652323F87304Q40356452-8AE2C90A-5231-48AE-BA88-E865B0B51AF5Q41297066-7CC96B78-C586-424E-BD2F-0C1946569FB9Q41517983-94140ED1-C512-422B-85BB-83F150BD14EDQ44218383-50B53C13-507C-470F-ADC5-72499578B68AQ45728977-BF652694-E4FF-4E5D-BEDA-63AF92520E63Q45729867-E2BCA460-76C0-4C19-B858-40125CB5454BQ45731142-5B23BF3E-8FC0-4B2E-A57C-B7B76FD2059CQ45899978-6338F801-F4FC-4B0D-B860-919B6B114B84Q46040519-4BE6C309-B854-4121-9EB9-763D29C1A7CBQ46329637-E39ACA94-CD9A-4E2A-8C0D-8D544B7F3F08Q46417676-E5C3E365-BF96-495C-B4B8-344EEECA3CC7Q46418064-86849F11-1E5D-4D73-A1AF-1F86D2A8CE23Q46486633-3C926653-705B-4E20-9CFC-5555FD8D17ACQ46580246-88B78D72-847E-4654-B17A-F7F81C737463
P50
name
Thierry Lacaze-Masmonteil
@ast
Thierry Lacaze-Masmonteil
@en
Thierry Lacaze-Masmonteil
@es
Thierry Lacaze-Masmonteil
@nl
type
label
Thierry Lacaze-Masmonteil
@ast
Thierry Lacaze-Masmonteil
@en
Thierry Lacaze-Masmonteil
@es
Thierry Lacaze-Masmonteil
@nl
prefLabel
Thierry Lacaze-Masmonteil
@ast
Thierry Lacaze-Masmonteil
@en
Thierry Lacaze-Masmonteil
@es
Thierry Lacaze-Masmonteil
@nl